Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/3801
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nodira I. Tursunova, Dilbar M. Almuradova, Khadicha Kh. Turayeva, Dilsora I. Mukimovaю | - |
dc.date.accessioned | 2022-10-12T14:10:41Z | - |
dc.date.available | 2022-10-12T14:10:41Z | - |
dc.date.issued | 2022 | - |
dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/3801 | - |
dc.description.abstract | Prevalence of germline BRCA mutations has been estimated to be about 1:1,600 women in the general population. Rate of BRCA1/2 mutations in Ashkenazi Jews population is 98-99%. Rate of BRCA1/2 mutations in Russian population is high – 28.4%. The average woman's lifetime risk of developing breast cancer is about 12%. In women with the BRCA1 mutation, the risk rises to about 72%, and in women with the BRCA2 mutation, to about 69%. They are also at a higher risk of getting cancer of a second breast after the first - the risk of developing contralateral breast cancer is about 40%. | en_US |
dc.language.iso | other | en_US |
dc.publisher | Other | en_US |
dc.subject | Hereditary breast and ovarian cancer , BRCA1/2 mutations, genetic test. | en_US |
dc.title | Hereditary breast and ovarian cancer | en_US |
dc.type | Article | en_US |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Образование и наука в XXI веке -1.pdf | Hereditary breast and ovarian cancer | 847.75 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.